Boca Raton, FL12 Active Studies

Myasthenia Gravis Clinical Trials in Boca Raton, FL

Find 12 actively recruiting myasthenia gravis clinical trials in Boca Raton, FL. Connect with local research sites and explore new treatment options.

12
Active Trials
9
Sponsors
2,085
Enrolling

Recruiting Myasthenia Gravis Studies in Boca Raton

About Myasthenia Gravis Clinical Trials in Boca Raton

Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles responsible for breathing and movement. It occurs when communication between nerves and muscles is disrupted. Treatment includes medications that improve neuromuscular transmission and immunosuppressive therapies.

There are currently 12 myasthenia gravis clinical trials recruiting participants in Boca Raton, FL. These studies are seeking a combined 2,085 participants. Research is being sponsored by argenx, Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany, Janssen Research & Development, LLC and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myasthenia Gravis Clinical Trials in Boca Raton — FAQ

Are there myasthenia gravis clinical trials in Boca Raton?

Yes, there are 12 myasthenia gravis clinical trials currently recruiting in Boca Raton, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boca Raton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boca Raton research site will contact you about next steps.

Are clinical trials in Boca Raton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boca Raton studies also compensate for your time and travel.

What myasthenia gravis treatments are being tested?

The 12 active trials in Boca Raton are testing new therapies including novel drugs, biologics, and treatment approaches for myasthenia gravis.

Data updated July 20, 2026 from ClinicalTrials.gov